Search Results - "КОМПЛЕКСНОЕ ЛЕЧЕНИЕ"

Source: International Journal of Scientific Pediatrics; Vol. 4 No. 1 (2025): January-February; 801-803 ; Международный журнал научной педиатрии; Том 4 № 1 (2025): Январь-Февраль; 801-803 ; Xalqaro ilmiy pediatriya jurnali; Nashr soni. 4 No. 1 (2025): Yanvar-Fevral; 801-803 ; 2181-2926

Subject Terms: лечение, хламидийная пневмония, дети, комплексное лечение, treatment, chlamydial pneumonia, children, complex treatment, davolash, xlamidiyali pnevmoniya, bolalar, kompleks

File Description: application/pdf

Relation: https://ijsp.uz/index.php/journal/article/view/295/238; https://ijsp.uz/index.php/journal/article/view/295

Availability: https://ijsp.uz/index.php/journal/article/view/295
https://doi.org/10.56121/2181-2926-2025-4-1-801-803

View record from BASE

10

Academic Journal

OPTIMIZATION OF NEPHROGENIC SEPSIS REHABILITATION IN CHILDREN ; ОПТИМИЗАЦИЯ РЕАБИЛИТАЦИИ НЕФРОГЕННОГО СЕПСИСА У ДЕТЕЙ ; BOLАLАRDА NEFROGEN SEPSISNI REАBILITАTSIYA QILISHNI OPTIMАLLАSHTIRISH

Authors: Karimdjanov, Ilxamjan, Dinmukhamadieva, Dilorom, Xoltayeva, Fotima, Tursunbayev, Anvar

Source: Medical science of Uzbekistan; No. 2 (2025): March-April; 161-163 ; Медицинская наука Узбекистана; № 2 (2025): Март-Апрель; 161-163 ; O`zbekiston tibbiyot ilmi; No. 2 (2025): Mart-Aprel; 161-163 ; 2181-3612

Subject Terms: nephrogenic sepsis, Nefroton Kids, comprehensive treatment, antibiotic therapy, нефрогенный сепсис, Нефротон Кидс, комплексное лечение, антибиотикотерапии, nefrogen sepsis, kompleks davolash, antibiotik terapiya

File Description: application/pdf

Relation: https://fdoctors.uz/index.php/journal/article/view/142/108; https://fdoctors.uz/index.php/journal/article/view/142

Availability: https://fdoctors.uz/index.php/journal/article/view/142
https://doi.org/10.56121/2181-3612-2025-2-161-163

View record from BASE

11

Academic Journal

Эффективность комплексного лечения диссеминированного туберкулеза с множественной и широкой лекарственной устойчивостью, сочетанного с ВИЧ-инфекцией

Subject Terms: disseminated pulmonary tuberculosis, ВИЧ-инфекция, multidrug resistance, comprehensive treatment, extensive drug resistance, широкая лекарственная устойчивость, комплексное лечение, множественная лекарственная устойчивость, HIV infection, диссеминированный туберкулез легких, 3. Good health

12

Academic Journal

THE COMPARISON OF LIFE’S QUALITY OF PATIENTS WITH CONCOMITANT GENITAL PROLAPSE BEFORE AND AFTER COMPLEX AND STAGED SURGICAL TREATMENT. NON-RANDOMIZED CONTROLLED TRIAL: ОЦЕНКА КАЧЕСТВА ЖИЗНИ ПАЦИЕНТОВ С СОЧЕТАННЫМ ГЕНИТАЛЬНЫМ ПРОЛАПСОМ ДО И ПОСЛЕ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ПРИ КОМПЛЕКСНОМ И ЭТАПНОМ ЛЕЧЕНИИ В СРАВНИТЕЛЬНОМ АСПЕКТЕ. НЕРАНДОМИЗИРОВАННОЕ КОНТРОЛИРУЕМОЕ ИССЛЕДОВАНИЕ

Authors: Laktionova, M., Askerov, A., Kulzhanov, M., Aringazina, A., Baimuratova, M., Zhaganova, S., Barmanasheva, Z., Smagina, I.

Source: Наука и здравоохранение. :60-65

13

Academic Journal

THE USE OF LIGHT THERAPY IN THE COMPLEX THERAPY OF HERPETIC STOMATITIS

Source: НАУКА, НОВЫЕ ТЕХНОЛОГИИ И ИННОВАЦИИ КЫРГЫЗСТАНА. :155-159

Subject Terms: инфекция, clinical features, treatment, светолечение, diagnosis, herpes, диагностика, комплексное лечение, лечение, herpetic stomatitis, infection, 3. Good health, complex treatment, герпетический стоматит, клинические особенности, герпес, phototherapy

14

Academic Journal

СОВЕРШЕНСТВОВАНИЕ КОМПЛЕКСНОГО ЛЕЧЕНИЯ ГНОЙНЫХ ХИРУРГИЧЕСКИХ БОЛЬНЫХ С СОПУТСТВУЮЩИЕ ЗАБОЛЕВАНИЯМИ

Authors: Сайфуллоевна, Шарапова Малохат

Source: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 5 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 367-374 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 5 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 367-374 ; 2181-3469

Subject Terms: Слова: сахарный диабет, гнойная хирургическая инфекция, гангрена, диффузный токсический зоб, комплексное лечение

File Description: application/pdf

Relation: https://sciencebox.uz/index.php/amaltibbiyot/article/view/10734/9796; https://sciencebox.uz/index.php/amaltibbiyot/article/view/10734

Availability: https://sciencebox.uz/index.php/amaltibbiyot/article/view/10734

View record from BASE

15

Academic Journal

Basic surgical principles for locally advanced rectal cancer in complex therapy ; Преемственность принципов онкохирургии при выполнении оперативных вмешательств по поводу местнораспространенного рака прямой кишки в условиях комплексной терапии

Authors: Yu. A. Barsukov, Z. Z. Mamedli, O. A. Vlasov, V. A. Aliev, V. M. Kulushev, A. G. Perevoshchikov, Z. A. Dudaev, D. Kh. Khudoerov, Ю. А. Барсуков, З. З. Мамедли, О. А. Власов, В. А. Алиев, В. М. Кулушев, А. Г. Перевощиков, З. А. Дудаев, Д. Х. Худоеров

Source: Siberian journal of oncology; Том 23, № 5 (2024); 85-92 ; Сибирский онкологический журнал; Том 23, № 5 (2024); 85-92 ; 2312-3168 ; 1814-4861

Subject Terms: сфинктеросохраняющие операции, combined modality treatment, principles of surgical oncology, sphincter-preserving surgeries, комплексное лечение, онкологическая адекватность

File Description: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/3271/1273; Барсуков Ю.А. Рак прямой кишки и анального канала: перспективы комбинированного лечения. Руководство для врачей. М., 2019. 856 с.; Capirci C., Rubello D., Pasini F., Galeotti F., Bianchini E., Del Favero G., Panzavolta R., Crepaldi G., Rampin L., Facci E., Gava M., Banti E., Marano G. The role of dual-time combined 18-fuorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys. 2009; 74(5): 1461–9. doi:10.1016/j.ijrobp.2008.10.064.; Horisberger K., Treschl A., Mai S., Barreto-Miranda M., Kienle P., Ströbel P., Erben P., Woernle C., Dinter D., Kähler G., Hochhaus A., Post S., Willeke F., Wenz F., Hofheinz R.D.; MARGIT (Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren). Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. Int J Radiat Oncol Biol Phys. 2009; 74(5): 1487–93. doi:10.1016/j.ijrobp.2008.10.014.; Glynne-Jones R., Wyrwicz L., Tiret E., Brown G., Rödel C., Cervantes A., Arnold D.; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017; 28(s4): 22–40. doi:10.1093/annonc/mdx224. Erratum in: Ann Oncol. 2018; 29(s4). doi:10.1093/annonc/mdy161.; The Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013; 100(8): 1009–14. doi : 10.1002/bjs.9192.; Барсуков Ю.А., Ткачев С.И., Мамедли З.З., Алиев В.А., Власов О.А., Вайнсон А.А., Перевощиков А.Г., Кулушев В.М., Иванов С.В., Хайленко В.А., Николаев А.В., Олтаржевская Н.Д., Коровина М.А., Ковалева Ю.Ю., Дудаев З.А. Комплексное лечение больных раком прямой кишки: методические рекомендации. М., 2023. 56 с.; Давыдов М.И. Этюды онкохирургии. М., 2009. 46 с.; Abel A.L. The modern treatment of cancer the colon and rectum. Milwaukee Proc. 1931; 296–300. Цит. по: Büchler M.W., Heald R.J., Ulrich B., Weits J. (eds). Rectal Cancer Treatment. Springer, Berlin, 2005. 280 p.; Холдин С.А. Злокачественные новообразования прямой кишки. Л., 1955. 360 с.; Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surgery. 1982; 69(10): 613–16.; Барсуков Ю.А., Мамедли З.З., Ткачев С.И., Алиев В.А., Власов О.А., Перевощиков А.Г., Олтаржевская Н.Д., Коровина М.А., Дудаев З.А., Гончаров С.В., Иванов С.М. Методологические аспекты комплексной терапии местнораспространенного рака прямой кишки. Онкология. Журнал им. П.А. Герцена. 2024; 13(3): 20–26. doi:10.17116/onkolog20241303120.; Лавникова Г.А., Гош Т.Е., Талалаева А.В., Кобозева С.А, Червонная Л.В. Гистологический метод количественной оценки степени лучевого повреждения опухоли. Медицинская радиология. 1978; 23(3): 6–9.; Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997; 12(1): 19–23. doi:10.1007/s003840050072.; https://www.siboncoj.ru/jour/article/view/3271

Availability: https://www.siboncoj.ru/jour/article/view/3271
https://doi.org/10.21294/1814-4861-2024-23-5-85-92

View record from BASE

16

Academic Journal

Impact of molecular genetic profle of meningiomas on the clinical course and recurrence using combined modality treatment ; Влияние молекулярно-генетического профиля менингиом на течение заболевания и рецидивирование при использовании комбинированного метода лечения

Authors: G. S. Sergeev, A. S. Gaytan, M. A. Travin, A. B. Ponomarev, M. A. Afonina, I. A. Savitskaya, F. Yakhya, A. L. Krivoshapkin, Г. С. Сергеев, А. С. Гайтан, М. А. Травин, А. Б. Пономарев, М. А. Афонина, И. А. Савицкая, Ф. Яхья, А. Л. Кривошапкин

Source: Siberian journal of oncology; Том 22, № 6 (2023); 138-152 ; Сибирский онкологический журнал; Том 22, № 6 (2023); 138-152 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2017-0-31-36

Subject Terms: терапевтические мишени, genomic and proteomic analysis, mesenchymal tumors of the CNS, targeted treatment, геномный и протеомный анализ, мезенхимальные опухоли ЦНС, комплексное лечение менингиом

File Description: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/2844/1189; Ostrom Q.T., Price M., Neff C., Cioff G., Waite K.A., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019. Neuro Oncol. 2022; 24(s5): 1–95. doi:10.1093/neuonc/noac202.; Pearson B.E., Markert J.M., Fisher W.S., Guthrie B.L., Fiveash J.B., Palmer C.A., Riley K. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus. 2008; 24(5). doi:10.3171/FOC/2008/24/5/E3.; Hsu D.W., Efrd J.T., Hedley-Whyte E.T. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg. 1997; 86(1): 113–20. doi:10.3171/jns.1997.86.1.0113.; Ribalta T., McCutcheon I.E., Aldape K.D., Bruner J.M., Fuller G.N. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004; 28(11): 1532–6. doi:10.1097/01.pas.0000141389.06925.d5.; Artlich A., Schmidt D. Immunohistochemical profle of meningiomas and their histological subtypes. Hum Pathol. 1990; 21(8): 843–9. doi:10.1016/0046-8177(90)90054-9.; Schnitt S.J., Vogel H. Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol. 1986; 10(9): 640–9. doi:10.1097/00000478-198609000-00006.; Kalamarides M., Niwa-Kawakita M., Leblois H., Abramowski V., Perricaudet M., Janin A., Thomas G., Gutmann D.H., Giovannini M. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev. 2002; 16(9): 1060–5. doi:10.1101/gad.226302.; Abedalthagaf M.S., Merrill P.H., Bi W.L., Jones R.T., Listewnik M.L., Ramkissoon S.H., Thorner A.R., Dunn I.F., Beroukhim R., Alexander B.M., Brastianos P.K., Francis J.M., Folkerth R.D., Ligon K.L., Van Hummelen P., Ligon A.H., Santagata S. Angiomatous meningiomas have a distinct genetic profle with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget. 2014; 5(21): 10596–606. doi:10.18632/oncotarget.2517.; Bi W.L., Abedalthagaf M., Horowitz P., Agarwalla P.K., Mei Y., Aizer A.A., Brewster R., Dunn G.P., Al-Mefty O., Alexander B.M., Santagata S., Beroukhim R., Dunn I.F. Genomic landscape of intracranial meningiomas. J Neurosurg. 2016; 125(3): 525–35. doi:10.3171/2015.6.JNS15591.; Abedalthagaf M., Bi W.L., Aizer A.A., Merrill P.H., Brewster R., Agarwalla P.K., Listewnik M.L., Dias-Santagata D., Thorner A.R., van Hummelen P., Brastianos P.K., Reardon D.A., Wen P.Y., Al-Mefty O., Ramkissoon S.H., Folkerth R.D., Ligon K.L., Ligon A.H., Alexander B.M., Dunn I.F., Beroukhim R., Santagata S. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016; 18(5): 649–55. doi:10.1093/neuonc/nov316.; Choy W., Kim W., Nagasawa D., Stramotas S., Yew A., Gopen Q., Parsa A.T., Yang I. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus. 2011; 30(5). doi:10.3171/2011.2.FOCUS1116.; Collord G., Tarpey P., Kurbatova N., Martincorena I., Moran S., Castro M., Nagy T., Bignell G., Maura F., Young M.D., Berna J., Tubio J.M.C., McMurran C.E., Young A.M.H., Sanders M., Noorani I., Price S.J., Watts C., Leipnitz E., Kirsch M., Schackert G., Pearson D., Devadass A., Ram Z., Collins V.P., Allinson K., Jenkinson M.D., Zakaria R., Syed K., Hanemann C.O., Dunn J., McDermott M.W., Kirollos R.W., Vassiliou G.S., Esteller M., Behjati S., Brazma A., Santarius T., McDermott U. An integrated genomic analysis of anaplastic meningioma identifes prognostic molecular signatures. Sci Rep. 2018; 8(1). doi:10.1038/s41598-018-31659-0.; Sievers P., Sill M., Blume C., Tauziede-Espariat A., Schrimpf D., Stichel D., Reuss D.E., Dogan H., Hartmann C., Mawrin C., Hasselblatt M., Stummer W., Schick U., Hench J., Frank S., Ketter R., Schweizer L., Schittenhelm J., Puget S., Brandner S., Jaunmuktane Z., Küsters B., Abdullaev Z., Pekmezci M., Snuderl M., Ratliff M., Herold-Mende C., Unterberg A., Aldape K., Ellison D.W., Wesseling P., Reifenberger G., Wick W., Perry A., Varlet P., Pfster S.M., Jones D.T.W., von Deimling A., Sahm F.; German Consortium “Aggressive Meningiomas”. Clear cell meningiomas are defned by a highly distinct DNA methylation profle and mutations in SMARCE1. Acta Neuropathol. 2021; 141(2): 281–90. doi:10.1007/s00401-020-02247-2.; Schmidt M., Mock A., Jungk C., Sahm F., Ull A.T., Warta R., Lamszus K., Gousias K., Ketter R., Roesch S., Rapp C., Schefzyk S., Urbschat S., Lahrmann B., Kessler A.F., Löhr M., Senft C., Grabe N., Reuss D., Beckhove P., Westphal M., von Deimling A., Unterberg A., Simon M., Herold-Mende C. Transcriptomic analysis of aggressive meningiomas identifes PTTG1 and LEPR as prognostic biomarkers independent of WHO grade. Oncotarget. 2016; 7(12): 14551–68. doi:10.18632/oncotarget.7396.; Sahm F., Schrimpf D., Stichel D., Jones D.T.W., Hielscher T., Schefzyk S., Okonechnikov K., Koelsche C., Reuss D.E., Capper D., Sturm D., Wirsching H.G., Berghoff A.S., Baumgarten P., Kratz A., Huang K., Wefers A.K., Hovestadt V., Sill M., Ellis H.P., Kurian K.M., Okuducu A.F., Jungk C., Drueschler K., Schick M., Bewerunge-Hudler M., Mawrin C., Seiz-Rosenhagen M., Ketter R., Simon M., Westphal M., Lamszus K., Becker A., Koch A., Schittenhelm J., Rushing E.J., Collins V.P., Brehmer S., Chavez L., Platten M., Hänggi D., Unterberg A., Paulus W., Wick W., Pfster S.M., Mittelbronn M., Preusser M., Herold-Mende C., Weller M., von Deimling A. DNA methylation-based classifcation and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017; 18(5): 682–94. doi:10.1016/S1470-2045(17)30155-9.; Dunn J., Ferluga S., Sharma V., Futschik M., Hilton D.A., Adams C.L., Lasonder E., Hanemann C.O. Proteomic analysis discovers the diferential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism. EBioMedicine. 2019; 40: 77–91. doi:10.1016/j.ebiom.2018.12.048.; Parada C.A., Osbun J., Kaur S., Yakkioui Y., Shi M., Pan C., Busald T., Karasozen Y., Gonzalez-Cuyar L.F., Rostomily R., Zhang J., Ferreira M. Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression. Sci Rep. 2018; 8(1): 2098. doi:10.1038/s41598-018-19308-y.; Cui G.Q., Jiao A.H., Xiu C.M., Wang Y.B., Sun P., Zhang L.M., Li X.G. Proteomic analysis of meningiomas. Acta Neurol Belg. 2014; 114(3): 187–94. doi:10.1007/s13760-013-0253-z.; Dumic J., Dabelic S., Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta. 2006; 1760(4): 616–35. doi:10.1016/j.bbagen.2005.12.020.; Wibom C., Mörén L., Aarhus M., Knappskog P.M., Lund-Johansen M., Antti H., Bergenheim A.T. Proteomic profles difer between bone invasive and noninvasive benign meningiomas of fbrous and meningothelial subtype. J Neurooncol. 2009; 94(3): 321–31. doi:10.1007/s11060-009-9865-9.; Okamoto H., Li J., Vortmeyer A.O., Jaffe H., Lee Y.S., Gläsker S., Sohn T.S., Zeng W., Ikejiri B., Proescholdt M.A., Mayer C., Weil R.J., Oldfeld E.H., Zhuang Z. Comparative proteomic profles of meningioma subtypes. Cancer Res. 2006; 66(20): 10199–204. doi:10.1158/0008-5472.CAN-06-0955.; Dunn J., Lenis V.P., Hilton D.A., Warta R., Herold-Mende C., Hanemann C.O., Futschik M.E. Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma. Cancers (Basel). 2020; 12(11): 3270. doi:10.3390/cancers12113270.; Louis D.N., Perry A., Wesseling P., Brat D.J., Cree I.A., Figarella-Branger D., Hawkins C., Ng H.K., Pfster S.M., Reifenberger G., Soffetti R., von Deimling A., Ellison D.W. The 2021 WHO Classifcation of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021; 23(8): 1231–51. doi:10.1093/neuonc/noab106.; Bendszus M., Martin-Schrader I., Warmuth-Metz M., Hofmann E., Solymosi L. MR imaging- and MR spectroscopy-revealed changes in meningiomas for which embolization was performed without subsequent surgery. Am J Neuroradiol. 2000; 21(4): 666–9.; Romani R., Tang W.J., Mao Y., Wang D.J., Tang H.L., Zhu F.P., Che X.M., Gong Y., Zheng K., Zhong P., Li S.Q., Bao W.M., Benner C., Wu J.S., Zhou L.F. Difusion tensor magnetic resonance imaging for predicting the consistency of intracranial meningiomas. Acta Neurochir (Wien). 2014; 156(10): 1837–45. doi:10.1007/s00701-014-2149-y.; Kashimura H., Inoue T., Ogasawara K., Arai H., Otawara Y., Kanbara Y., Ogawa A. Prediction of meningioma consistency using fractional anisotropy value measured by magnetic resonance imaging. J Neurosurg. 2007; 107(4): 784–7. doi:10.3171/JNS-07/10/0784.; Sitthinamsuwan B., Khampalikit I., Nunta-aree S., Srirabheebhat P., Witthiwej T., Nitising A. Predictors of meningioma consistency: A study in 243 consecutive cases. Acta Neurochir (Wien). 2012; 154: 1383–9. doi:10.1007/s00701-012-1427-9.; Lee J.G., Song S.W., Koh Y.C., Cho J., Choi J.W., Roh H.G., Lim S.D. Primary intracranial fbrosarcoma presenting with hemorrhage. Brain Tumor Res Treat. 2013; 1(2): 9–4. doi:10.14791/btrt.2013.1.2.91.; Liu G., Chen Z.Y., Ma L., Lou X., Li S.J., Wang Y.L. Intracranial hemangiopericytoma: MR imaging fndings and diagnostic usefulness of minimum ADC values. J Magn Reson Imaging. 2013; 38(5): 1146–51. doi:10.1002/jmri.24075.; Ma C., Xu F., Xiao Y.D., Paudel R., Sun Y., Xiao E.H. Magnetic resonance imaging of intracranial hemangiopericytoma and correlation with pathological fndings. Oncol Lett. 2014; 8: 2140–4. doi:10.3892/ol.2014.2503.; Murphy M.C., Huston J., Glaser K.J., Manduca A., Meyer F.B., Lanzino G., Morris J.M., Felmlee J.P., Ehman R.L. Preoperative assessment of meningioma stifness using magnetic resonance elastography. J Neurosurg. 2013; 118(3): 643–8. doi:10.3171/2012.9.JNS12519.; Krivoshapkin A.L., Sergeev G.S., Kalneus L.E., Gaytan A.S., Murtazin V.I., Kurbatov V.P., Volkov A.M., Kostromskaya D.V., Pyatov S.M., Amelin M.E., Duishobaev A.R. New Software for Preoperative Diagnostics of Meningeal Tumor Histologic Types. World Neurosurg. 2016; 90: 123–32. doi:10.1016/j.wneu.2016.02.084.; Braunstein J.B., Vick N.A. Meningiomas: the decision not to operate. Neurology. 1997; 48(5): 1459–62. doi:10.1212/wnl.48.5.1459.; Akeyson E.W., McCutcheon I.E. Management of benign and aggressive intracranial meningiomas. Oncology (Huntington) 1996; 10(5): 747–56.; Chamberlain M.C. Intracerebral Meningiomas. Curr Treat Options Neurol. 2004; 6(4): 297–305. doi:10.1007/s11940-004-0029-0.; Goldsmith B.J., Wara W.M., Wilson C.B., Larson D.A. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg. 1994; 80(2): 195–201. doi:10.3171/jns.1994.80.2.0195.; Wilson C.B. Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. J Neurosurg. 1994; 81(5): 666–75. doi:10.3171/jns.1994.81.5.0666.; Kokubo M., Shibamoto Y., Takahashi J.A., Sasai K., Oya N., Hashimoto N., Hiraoka M. Efcacy of conventional radiotherapy for recurrent meningioma. J Neurooncol. 2000; 48(1): 51–5. doi:10.1023/a:1006430102406.; Jääskeläinen J., Haltia M., Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol. 1986; 25(3): 233–42. doi:10.1016/0090-3019(86)90233-8.; Hug E.B., Devries A., Thornton A.F., Munzenride J.E., Pardo F.S., Hedley-Whyte E.T., Bussiere M.R., Ojemann R. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol. 2000; 48(2): 151–60. doi:10.1023/a:1006434124794.; Horbinski C., Nabors L.B., Portnow J., Baehring J., Bhatia A., Bloch O., Brem S., Butowski N., Cannon D.M., Chao S., Chheda M.G., Fabiano A.J., Forsyth P., Gigilio P., Hattangadi-Gluth J., Holdhoff M., Junck L., Kaley T., Merrell R., Mrugala M.M., Nagpal S., Nedzi L.A., Nevel K., Nghiemphu P.L., Parney I., Patel T.R., Peters K., Puduvalli V.K., Rockhill J., Rusthoven C., Shonka N., Swinnen L.J., Weiss S., Wen P.Y., Willmarth N.E., Bergman M.A., Darlow S. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. J Natl Compr Canc Netw. 2023; 21(1): 12–20. doi:10.6004/jnccn.2023.0002.; Rogers L., Zhang P., Vogelbaum M.A., Perry A., Ashby L.S., Modi J.M., Alleman A.M., Galvin J., Brachman D., Jenrette J.M., De Groot J., Bovi J.A., Werner-Wasik M., Knisely J.P.S., Mehta M.P. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg. 2018; 129(1): 35–47. doi:10.3171/2016.11.JNS161170. Epub 2017 Oct 6. Erratum in: J Neurosurg. 2018; 129(6): 1650.; Weber D.C., Ares C., Villa S., Peerdeman S.M., Renard L., Baumert B.G., Lucas A., Veninga T., Pica A., Jefferies S., Ricardi U., Miralbell R., Stelmes J.J., Liu Y., Collette L., Collette S. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042). Radiother Oncol. 2018; 128(2): 260–5. doi:10.1016/j.radonc.2018.06.018.; Chen W.C., Perlow H.K., Choudhury A., Nguyen M.P., Mirchia K., Youngblood M.W., Lucas C.G., Palmer J.D., Magill S.T., Raleigh D.R. Radiotherapy for meningiomas. J Neurooncol. 2022; 160(2): 505–15. doi:10.1007/s11060-022-04171-9.; Agnihotri S., Suppiah S., Tonge P.D., Jalali S., Danesh A., Bruce J.P., Mamatjan Y., Klironomos G., Gonen L., Au K., Mansouri S., Karimi S., Sahm F., von Deimling A., Taylor M.D., Laperriere N.J., Pugh T.J., Aldape K.D., Zadeh G. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas. Nat Commun. 2017; 8(1): 186. doi:10.1038/s41467-017-00174-7.; Gillespie C.S., Islim A.I., Taweel B.A., Millward C.P., Kumar S., Rathi N., Mehta S., Haylock B.J., Thorp N., Gilkes C.E., Lawson D.D.A., Mills S.J., Chavredakis E., Farah J.O., Brodbelt A.R., Jenkinson M.D. The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring. J Neurooncol. 2021; 153(2): 239–49. doi:10.1007/s11060-021-03761-3.; Horbinski C., Nabors L.B., Portnow J., Baehring J., Bhatia A., Bloch O., Brem S., Butowski N., Cannon D.M., Chao S., Chheda M.G., Fabiano A.J., Forsyth P., Gigilio P., Hattangadi-Gluth J., Holdhoff M., Junck L., Kaley T., Merrell R., Mrugala M.M., Nagpal S., Nedzi L.A., Nevel K., Nghiemphu P.L., Parney I., Patel T.R., Peters K., Puduvalli V.K., Rockhill J., Rusthoven C., Shonka N., Swinnen L.J., Weiss S., Wen P.Y., Willmarth N.E., Bergman M.A., Darlow S. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. 2023; 21(1). doi:10.6004/jnccn.2023.0002.; Dubel G.J., Ahn S.H., Soares G.M. Contemporary endovascular embolotherapy of meningioma. Semin Intervent Radiol. 2013; 30(3): 263–77. doi:10.1055/s-0033-1353479.; Engelhard H.H. Progress in the diagnosis and treatment of patients with meningiomas. Part I: diagnostic imaging, preoperative embolization. Surg Neurol. 2001; 55(2): 89–101. doi:10.1016/s0090- 3019(01)00349-4.; Dowd C.F., Halbach V.V., Higashida R.T. Meningiomas: the role of preoperative angiography and embolization. Neurosurg Focus. 2003; 15(1). doi:10.3171/foc.2003.15.1.10.; Bendszus M., Martin-Schrader I., Schlake H.P., Solymosi L. Embolisation of intracranial meningiomas without subsequent surgery. Neuroradiology. 2003; 45(7): 451–5. doi:10.1007/s00234-003-1005-1.; Koike T., Sasaki O., Tanaka R., Arai H. Long-term results in a case of meningioma treated by embolization alone – case report. Neurol Med Chir (Tokyo). 1990; 30(3): 173–7. doi:10.2176/nmc.30.173.; Wakhloo A.K., Juengling F.D., Van Velthoven V., Schumacher M., Hennig J., Schwechheimer K. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. Am J Neuroradiol. 1993; 14(3): 571–82.; Barresi V., Branca G., Granata F., Alafaci C., Caffo M., Tuccari G. Embolized meningiomas: risk of overgrading and neo-angiogenesis. J Neurooncol. 2013; 113(2): 207–19. doi:10.1007/s11060-013-1117-3.; Perry A., Chicoine M.R., Filiput E., Miller J.P., Cross D.T. Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Cancer. 2001; 92(3): 701–11. doi:10.1002/1097-0142(20010801)92:33.0.co;2-7.; Jensen R.L., Soleau S., Bhayani M.K., Christiansen D. Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg. 2002; 97(3): 658–67. doi:10.3171/jns.2002.97.3.0658.; https://www.siboncoj.ru/jour/article/view/2844

Availability: https://www.siboncoj.ru/jour/article/view/2844
https://doi.org/10.21294/1814-4861-2023-22-6-138-152

View record from BASE

17

Academic Journal

Kinesiotherapy in painful diabetic polyneuropathy ; Кинезиотерапия при болевой форме диабетической полиневропатии

Authors: E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova, Е. В. Мандра, В. А. Парфенов, Л. Т. Ахмеджанова, Е. С. Шулакова, В. В. Фадеев, М. В. Амосова

Contributors: The investigation has not been sponsored, Исследование не имело спонсорской поддержки

Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 16, No 4 (2024); 21-27 ; Неврология, нейропсихиатрия, психосоматика; Vol 16, No 4 (2024); 21-27 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2024-4

Subject Terms: комплексное лечение, painful diabetic polyneuropathy, kinesiotherapy, anxiety, depression, complex treatment, болевая диабетическая полиневропатия, кинезиотерапия, тревога, депрессия

File Description: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/2328/1698; Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition. Diabetes Res Clin Pract. 2020 Apr;162:108072. doi:10.1016/j.diabres.2020.108072. Epub 2020 Feb 13.; Дедов ИИ, Концевая АВ, Шестакова МВ и др. Экономические затраты на сахарный диабет 2 типа и его основные сердечно-сосудистые осложнения в Российской Федерации. Сахарный диабет. 2016;19(6):518-27. doi:10.14341/DM8153.; Khan KS, Andersen H. The Impact of Diabetic Neuropathy on Activities of Daily Living, Postural Balance and Risk of Falls – A Systematic Review. J Diabetes Sci Technol. 2022 Mar;16(2):289-94. doi:10.1177/1932296821997921. Epub 2021 Mar 14.; Ахмеджанова ЛТ, Мандра ЕВ. Болевая диабетическая полиневропатия: современные подходы к диагностике и лечению. Медицинский Совет. 2022;(23):86-92. doi:10.21518/2079-701X-2022-16-23-86-92; Selvarajah D, Kar D, Khunti K, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019 Dec;7(12):938-48. doi:10.1016/S2213-8587(19)30081-6. Epub 2019 Oct 14.; Abdissa D. Prevalence and associated factors of painful diabetic peripheral neuropathy among diabetic patients on follow up at Jimma University Medical Center. J Diabetes Metab Disord. 2020 Oct 15;19(2):1407-13. doi:10.1007/s40200-020-00661-7; Selvarajah D, Cash T, Sankar A, et al. The contributors of emotional distress in painful diabetic neuropathy. Diab Vasc Dis Res. 2014 Jul;11(4):218-25. doi:10.1177/1479164114522135. Epub 2014 May 12.; Zafeiri M, Tsioutis C, Kleinaki Z, et al. Clinical Characteristics of Patients with co-Existent Diabetic Peripheral Neuropathy and Depression : A Systematic Review. Exp Clin Endocrinol Diabetes. 2021 Feb;129(2):77-85. doi:10.1055/a-0741-6937. Epub 2018 Sep 26.; American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024. Diabetes Care. 2024 Jan 1;47(Suppl 1):S231-S243. doi:10.2337/dc24-S012; Elafros MA, Andersen H, Bennett DL, et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 2022 Oct;21(10):922-36. doi:10.1016/S1474-4422(22)00188-0; Racaru S, Sturt J, Celik A. The Effects of Psychological Interventions on Diabetic Peripheral Neuropathy : A Systematic Review and Meta-Analysis. Pain Manag Nurs. 2021 Jun;22(3):302-11. doi:10.1016/j.pmn.2020.11.001. Epub 2020 Dec 13.; Moisset X, Bouhassira D, Avez Couturier J, et al. Pharmacological and non-pharmacological treatments for neuropathic pain : Systematic review and French recommendations. Rev Neurol (Paris). 2020 May;176(5):325-52. doi:10.1016/j.neurol.2020.01.361. Epub 2020 Apr 7.; Manojlovic D, Kopse EI. The effectiveness of aerobic exercise for pain management in patients with fibromyalgia. Eur J Transl Myol. 2023 Jul 14;33(3):11423. doi:10.4081/ejtm.2023.11423; Парфенов ВА, Ламкова ИА. Эффективность кинезитерапии при хронической неспецифической люмбалгии. Анналы клинической и экспериментальной неврологии. 2021;15(3):35-42. doi:10.54101/ACEN.2021.3.4; Holmes CJ, Hastings MK. The Application of Exercise Training for Diabetic Peripheral Neuropathy. J Clin Med. 2021 Oct 28;10(21):5042. doi:10.3390/jcm10215042; Dyck PJ, Albers JW, Andersen H, et al; Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011 Oct;27(7):620-8. doi:10.1002/dmrr.1226; Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi:10.1002/acr.20543; Bastyr EJ 3rd, Price KL, Bril V; MBBQ Study Group. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther. 2005 Aug;27(8):1278-94. doi:10.1016/j.clinthera.2005.08.002; Beck AT, Steer RA, Brown G. Beck Depression Inventory–II [Database record]. APA. PsycTests. 1996. doi:10.1037/t00742-000; Spielberger CD. Test Anxiety Inventory: Preliminary professional manual. Menlo Park; 1980.; Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi:10.1249/01.MSS.0000078924.61453.FB; Shi Y, Wu W. Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress. BMC Med. 2023 Sep 29;21(1):372. doi:10.1186/s12916-023-03076-2; Sletten CD, Kurklinsky S, Chinburapa V, Ghazi S. Economic analysis of a comprehensive pain rehabilitation program: a collaboration between Florida Blue and Mayo Clinic Florida. Pain Med. 2015 May;16(5):898-904. doi:10.1111/pme.12679. Epub 2015 Feb 3.; Wilhelm JC, Xu M, Cucoranu D, et al. Cooperative roles of BDNF expression in neurons and Schwann cells are modulated by exercise to facilitate nerve regeneration. J Neurosci. 2012 Apr 4;32(14):5002-9. doi:10.1523/JNEUROSCI.1411-11.2012; Zaccaria S, Di Perna P, Giurato L, et al. Diabetic Polyneuropathy and Physical Activity in Type 1 Diabetes Mellitus: A Cross-Sectional Study. J Clin Med. 2023 Oct 18;12(20):6597. doi:10.3390/jcm12206597; Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006 Jun;29(6):1294-9. doi:10.2337/dc06-0224; Tatikola SP, Natarajan V, Desai VK, et al. Effect of various exercise protocols on neuropathic pain in individuals with type 2 diabetes with peripheral neuropathy : A systematic review and meta-analysis. Diabetes Metab Syndr. 2022 Sep;16(9):102603. doi:10.1016/j.dsx.2022.102603. Epub 2022 Aug 27.; Zhang YH, Hu HY, Xiong YC, et al. Exercise for Neuropathic Pain : A Systematic Review and Expert Consensus. Front Med (Lausanne). 2021 Nov 24;8:756940. doi:10.3389/fmed.2021.756940; Luo J, Zhu HQ, Gou B, Zheng YL. Mechanisms of exercise for diabetic neuropathic pain. Front Aging Neurosci. 2022 Oct 12;14:975453. doi:10.3389/fnagi.2022.975453; Leitzelar BN, Koltyn KF. Exercise and Neuropathic Pain : A General Overview of Preclinical and Clinical Research. Sports Med Open. 2021 Mar 22;7(1):21. doi:10.1186/s40798-021-00307-9; Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012 Sep-Oct;26(5):424-9. doi:10.1016/j.jdiacomp.2012.05.007. Epub 2012 Jun 18.; Hamed N, Raoof N. Effect of high intensity interval training on diabetic obese women with polyneuropathy: A randomized controlled clinical trial. Phys Ther Rehabil. 2014;1(4):1-8. doi:10.7243/2055-2386-1-4; Nadi M, Marandi SM, Esfarjani F, et al. The Comparison between Effects of 12 weeks Combined Training and Vitamin D Supplement on Improvement of Sensory-motor Neuropathy in type 2 Diabetic Women. Adv Biomed Res. 2017 May 2;6:55. doi:10.4103/2277-9175.205528; Stubbs EB Jr, Fisher MA, Miller CM, et al. Randomized Controlled Trial of Physical Exercise in Diabetic Veterans With Length-Dependent Distal Symmetric Polyneuropathy. Front Neurosci. 2019 Feb 11;13:51. doi:10.3389/fnins.2019.00051; Cox ER, Gajanand T, Burton NW, et al. Effect of different exercise training intensities on musculoskeletal and neuropathic pain in inactive individuals with type 2 diabetes – Preliminary randomised controlled trial. Diabetes Res Clin Pract. 2020 Jun;164:108168. doi:10.1016/j.diabres.2020.108168. Epub 2020 Apr 29.; Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012 Oct;142 Suppl:S8-21. doi:10.1016/S0165-0327(12)70004-6; Tang NKY, Salkovskis PM, Hodges A, et al. Effects of mood on pain responses and pain tolerance: an experimental study in chronic back pain patients. Pain. 2008 Aug 31;138(2):392-401. doi:10.1016/j.pain.2008.01.018. Epub 2008 Mar 5.; Price R, Smith D, Franklin G, et al. Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee. Neurology. 2022 Jan 4;98(1):31-43. doi:10.1212/WNL.0000000000013038; Головачева АА, Головачева ВА. Кинезиотерапия при хронической боли в спине и сочетанной головной боли напряжения. Российский неврологический журнал. 2023;28(3):61-8. doi:10.30629/2658-7947-2023-28-3-61-68; Головачева ВА, Табеева ГР, Фатеева ТГ. Ведение пациентов со скелетно-мышечной болью в спине и коморбидной тревогой. Медицинский Совет. 2022;(23):60-6. doi:10.21518/2079-701X-2022-16-23-60-66

Availability: https://nnp.ima-press.net/nnp/article/view/2328
https://doi.org/10.14412/2074-2711-2024-4-21-27

View record from BASE

18

Academic Journal

Tactics of surgical treatment of complications of abdominal-perineal extirpation of the rectum in a patient with locally advanced cancer against the background of combined treatment of the progression of the process. Clinical observation ; Тактика хирургического лечения осложнений брюшно-промежностной экстирпации прямой кишки у пациента с местно-распространенным раком на фоне комбинированного лечения прогрессирования процесса. Клиническое наблюдение

Authors: A. S. Yamshchikova, V. A. Korotkov, L. O. Petrov, M. R. Kasymov, V. V. Pasov, V. Yu. Skoropad, A. D. Kaprin, S. A. Ivanov, А. С. Ямщикова, В. А. Коротков, Л. О. Петров, М. Р. Касымов, В. В. Пасов, В. Ю. Скоропад, А. Д. Каприн, С. А. Иванов

Contributors: Исследование и публикация статьи осуществлены в рамках бюджетного финансирования.

Source: Andrology and Genital Surgery; Том 25, № 2 (2024); 127-132 ; Андрология и генитальная хирургия; Том 25, № 2 (2024); 127-132 ; 2412-8902 ; 2070-9781

Subject Terms: пластика VRAM-лоскутом, complex treatment, progression, pelvic abscess, surgical treatment, pelvic evisceration, lymphadenectomy, VRAM flap surgery, комплексное лечение, прогрессирование, абсцесс малого таза, хирургическое лечение, тазовая эвисцерация, лимфаденэктомия

File Description: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/767/590; Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под редакцией А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой, Москва, 2022.; Butt HZ, Salem MK, Vijaynagar B, Chaudhri S, Singh B. Perineal reconstruction after extra-levator abdominoperineal excision (eLAPE): a systematic review. Ann Surg. 2014;11:32-38; Haleh Paka, Leila Haji Maghsoudib, Ali Soltaniana, Farshid Gholamia. Surgical complications in colorectal cancer patients. Annals of Medicine and Surgery 55 (2020) 13–18.; Jorge Arredondo, Patricia Martínez, Jorge Baixauli, Carlos Pastor, Javier Rodríguez, Fernando Pardo, Fernando Rotellar, Ana Chopitea , José Luís Hernández-Lizoáin. Analysis of surgical complications of primary tumor resection after neoadjuvant treatment in stage IV colon cancer. J Gastrointest Oncol. 2014 Apr;5(2):148-53.; Marta Climent, Sean T. Martin. Complications of laparoscopic rectal cancer surgery. Climent et al . Mini-invasive Surg 2018;2:45; Stefi Nordkamp, Davy M. J. Creemers, Sofie Glazemakers, Stijn H. J. Ketelaers et al. Implementation of an Enhanced Recovery after Surgery Protocol in Advanced and Recurrent Rectal Cancer Patients after beyond Total Mesorectal Excision Surgery: A Feasibility Study. Cancers 2023, 15, 4523.; Musters GD, Buskens CJ, Bemelman WA, Tanis PJ. Perineal wound healing after abdominoperineal resection for rectal cancer: a systematic review and metaanalysis.Dis Colon Rectum. 2014;57:1129-1139; Chan S, Miller M, Ng R, Ross D, Roblin P, Carapeti E, Williams AB, George ML. The use of myodermal flaps to close the perineum after abdominoperineal removal of the rectum with adenocarcinoma. Colorectal Dis. 2010;12(6):555-560.; Tei TM, Stolzenburg T, Buntzen S, Laurberg S, Kjeldsen H. Use of transpelvic rectus abdominis musculocutaneous f lap for anal cancer salvage surgery. Dis Colon Rectum. 2015;53:112-115.; https://agx.abvpress.ru/jour/article/view/767

Availability: https://agx.abvpress.ru/jour/article/view/767
https://doi.org/10.62968/2070-9781-2024-25-2-127-132

View record from BASE

19

Academic Journal